Test Price
2,800 AED✅ Home Collection Available
NPC2 Gene Niemann-Pick Disease Type C2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NPC2 لمرض نيمان-بيك النوع C2 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM - 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with DHA-licensed genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الخلاصة التنفيذية: دقة تشخيصية بنسبة 99.9%، مع خدمة سحب منزلي معتمدة ومطابقة لمعايير الآيزو، وإرشاد سريري بعد الفحص، وتغطية تأمينية مباشرة عبر واتساب.
Overview
The NPC2 Gene Niemann-Pick Disease Type C2 Genetic Test analyses the entire coding region of the NPC2 gene using next‑generation sequencing to detect pathogenic variants responsible for this rare, progressive lysosomal storage disorder. This comprehensive test enables early diagnosis, carrier screening, and informed family planning for UAE families, aligning with 2026 DHA precision medicine guidelines.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | Full‑gene NGS with copy number variant detection | Biochemical enzyme assay or single‑variant PCR |
| Method | Next Generation Sequencing (NGS) | Colorimetric substrate analysis / Sanger sequencing limited to known hotspots |
| Speed | 3–4 Weeks (ISO‑accredited cold‑chain handling) | 4–6 Weeks (enzyme assay) or 2–3 Weeks (targeted panel) |
| Regulatory | 2026 DHA/MOHAP‑aligned, ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | May not include full gene analysis or UAE‑specific reporting |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) notes: “A positive NPC2 variant must be interpreted alongside biochemical markers and clinical imaging; this test alone cannot predict disease severity. I strongly urge every patient to review results with a metabolic geneticist or neurologist. This test is a critical step, but it is not the final word in your diagnosis.”
⚠ Medication Warning: Do not discontinue prescribed medication or supplements without consulting your doctor. Niemann‑Pick management, particularly symptomatic treatments, must never be stopped abruptly.
Essential Safety & Exclusion Criteria
- Exclusion: Patients unable to provide a venous blood sample or dry blood spot (e.g., severe haemophilia without specialist clearance).
- Exclusion: Active severe infection or febrile illness at time of collection – reschedule for at least 2 weeks after recovery.
- ER Red Flag: If the individual experiences new‑onset seizures, sudden loss of motor skills, or severe respiratory distress, proceed immediately to the nearest emergency department and inform them of the suspected metabolic disorder.
- Pre‑test Requirement: A genetic counselling session to construct a three‑generation pedigree and obtain informed consent is mandatory prior to sample collection, as per DHA genetic testing regulations.
Patient FAQ & Clinical Guidance
1. What is the NPC2 gene test for Niemann‑Pick disease type C2?
This next‑generation sequencing test identifies disease‑causing mutations within the NPC2 gene, providing definitive molecular confirmation of Niemann‑Pick disease type C2. It is recommended for individuals with developmental delay, hepatosplenomegaly, or abnormal vertical gaze, and for family members at risk. Results guide clinical management, therapy eligibility, and reproductive options.
ما هو فحص جين NPC2 لمرض نيمان-بيك النوع C2؟ هذا الفحص بتقنية التسلسل الجيني من الجيل التالي يحدد الطفرات المسببة للمرض داخل جين NPC2، مما يوفر تأكيداً جزيئياً قاطعاً للتشخيص ويُستخدم لتوجيه العلاج والخيارات الإنجابية.
2. What sample is required and how is it collected?
We accept whole blood (3–5 mL in EDTA tube), extracted DNA, or a one‑drop blood sample on an FTA card. Our home collection service deploys a DHA‑licensed phlebotomist using a cold‑chain transport kit to preserve DNA integrity. The process is painless, takes less than 10 minutes, and is suitable for all ages, including infants.
ما هي العينة المطلوبة وكيف يتم جمعها؟ تُقبل عينة دم وريدي أو حمض نووي مستخلص أو قطرة دم على بطاقة FTA، مع خدمة سحب منزلي متوافقة مع معايير هيئة الصحة بدبي ونظام السلسلة الباردة للحفاظ على الحمض النووي.
3. How long does it take to receive results and what support is provided afterwards?
Turnaround time is 3 to 4 weeks from sample arrival at our ISO‑accredited laboratory. Once results are ready, you will receive a secure electronic report and a complimentary 20‑minute teleconsultation with a DHA‑certified clinical geneticist to interpret findings, discuss implications, and plan next steps.
كم تستغرق النتائج وما الدعم المتاح بعدها؟ تظهر النتائج خلال 3 إلى 4 أسابيع، ويحصل المريض على تقرير إلكتروني آمن واستشارة هاتفية مجانية مع أخصائي جينات سريري معتمد من هيئة الصحة بدبي لشرح النتائج والخطوات التالية.
This is ordered by Clinical Geneticists, Neurologists, and General Physicians (Primary Care) and is fully compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE Personal Data Protection Law (PDPL), and CDS Law 2026 for minors. Genetic counselling is mandatory prior to testing. Laboratory accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians